Turning Point Brands Announces Second Quarter 2026 Results
Turning Point Brands, Inc. (TPB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Turning Point Brands Announces Second Quarter 2026 Results ● Q2 2026 Modern Oral Gross Revenue increased 149% to $87.0 million and Net Sales increased 128% to $68.4 million. Accounting for 48% of total company net sales, up from 26% in Q2 2025 ● Raising FY 2026 Moder
How this was made
The 30-second read
Why it matters
The most actionable update is the raised FY 2026 Modern Oral gross and net sales guidance, supported by triple-digit Modern Oral growth in Q2. However, profitability metrics (GAAP net income and adjusted EBITDA) declined sharply YoY, and SG&A rose materially, increasing execution risk.
Market read
Traders can update TPB positioning ahead of the scheduled earnings call based on the raised Modern Oral outlook and the disclosed profitability/mix tradeoffs.
What to watch
Gross profit growth is partly driven by a tariff refund and out-of-period COGS adjustments; traders should normalize margins and watch whether the Modern Oral mix sustains gross profit percentage (down to 56.9% from 62.5%).
Background
SEC 8-K Item 2.02 with Exhibit 99.1 press release covering Turning Point Brands Q2 2026 financial results and FY 2026 outlook.
Ticker impact
Turning Point Brands reports Q2 2026 results and raises FY 2026 Modern Oral gross and net sales guidance, with Modern Oral now 48% of net sales.
Likely near-term positive bias as traders reprice FY Modern Oral growth and margin trajectory, while monitoring the SG&A and adjusted EBITDA decline.
The filing includes explicit Q2 datapoints (Modern Oral gross revenue +149%, net sales +128%) and a quantified FY 2026 outlook update (Modern Oral gross $330-$350m, net $260-$270m; Adjusted EBITDA $70-$90m). The negative GAAP/adjusted profitability trend adds uncertainty but does not negate the guidance upgrade.
Market effects
Signals demand shift toward modern oral nicotine products and potential margin/mix dynamics for alternative smoking accessory manufacturers.
Primarily US-focused retail distribution footprint (220,000 outlets in North America) may influence sentiment toward domestic consumer nicotine categories.
Limited direct global read-through; guidance is company-specific and tied to its product mix and tariff-related accounting.
Counterpoint
The guidance raise may be offset by structurally higher SG&A and freight costs, and adjusted EBITDA fell 50% YoY despite revenue growth.
Key entities
- issuerTurning Point Brands, Inc.
Manufacturer and marketer/distributor of branded consumer products including alternative smoking accessories and consumables; subject of the 8-K.
- business_lineModern Oral
Product category highlighted as the growth driver, with Q2 gross revenue +149% and FY 2026 guidance raised.
- segmentStoker’s Products Segment
Largest segment (75% of net sales in the quarter) with Q2 net sales +54.5% driven by Modern Oral.
- segmentZig-Zag Products Segment
Smaller segment (25% of net sales in the quarter) with Q2 net sales down 24.8% YoY.
